At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,277 enrolled
Drug / intervention
Saliva test kitdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Rapid Turnaround, Home-based Saliva Testing for COVID-19
In Brief
A clinical study evaluating Saliva test kit for Covid19. Completed, enrolled 1,277 participants across 2 sites.
Detailed Summary
The aim of the study is to demonstrate the feasibility and validity of a saliva based home surveillance monitoring test for SARS-CoV-2 infection. Participants will be asked to carry out as many tests as are included in the bag they are provided, on a daily basis until they are used up.
Study Details
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedSep 2020
Enrollment StartNov 2020
Primary CompletionDec 2022
TodayJul 2026
First PostedSep 29, 2020
Enrollment StartNov 20, 2020
Primary CompletionDec 10, 2022
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 5.8 years ago
Interventions
Saliva test kitdevice
Kit including tube with closed reagents using loop-mediated isothermal amplification (LAMP) assay to detect SARS-CoV-2 virus.